C. Seliger

First name
C.
Last name
Seliger
Haedenkamp, T. M., Leitzmann, M. F., Linker, R. A., Meier, C., Becker, C., Jick, S., et al. (2022). Antimicrobial drug use and the risk of glioma: A case-control study. Cancer Med. http://doi.org/10.1002/cam4.5222
Seliger, C., Meier, C. R., Jick, S. S., Uhl, M., Bogdahn, U., Hau, P., & Leitzmann, M. F. (2016). Use of cardiac glycosides and risk of glioma. J Neurooncol. http://doi.org/10.1007/s11060-015-2036-2
Seliger, C., Meier, C. R., Becker, C., Jick, S. S., Bogdahn, U., Hau, P., & Leitzmann, M. F. (2016). Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma. PLoS One. http://doi.org/10.1371/journal.pone.0149293
Seliger, C., Meier, C. R., Becker, C., Jick, S. S., Bogdahn, U., Hau, P., & Leitzmann, M. F. (2016). Statin use and risk of glioma: population-based case-control analysis. Eur J Epidemiol. http://doi.org/10.1007/s10654-016-0145-7
Seliger, C., Ricci, C., Meier, C. R., Bodmer, M., Jick, S. S., Bogdahn, U., et al. (2016). Diabetes, use of antidiabetic drugs, and the risk of glioma. Neuro Oncol. http://doi.org/10.1093/neuonc/nov100
Seliger, C., Meier, C. R., Becker, C., Jick, S. S., Proescholdt, M., Bogdahn, U., et al. (2017). Metabolic syndrome in relation to risk of meningioma. Oncotarget. http://doi.org/10.18632/oncotarget.13667
Seliger, C., Meier, C. R., Becker, C., Jick, S. S., Proescholdt, M., Bogdahn, U., et al. (2017). Diabetes, use of metformin, and the risk of meningioma. PLoS One. http://doi.org/10.1371/journal.pone.0181089
Anssar, T. M., Leitzmann, M. F., Linker, R. A., Meier, C., Becker, C., Jick, S., et al. (2019). Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma. Cancer Med. http://doi.org/10.1002/cam4.2767